These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2101302)

  • 21. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
    Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Alzheimer's plaques, tangles and memory deficits may have a common origin. Part IV: can calpain act as alpha-secretase?
    Chen M; Fernandez HL
    Front Biosci; 1998 Dec; 3():A66-75. PubMed ID: 9851910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An update on the amyloid hypothesis.
    Eckman CB; Eckman EA
    Neurol Clin; 2007 Aug; 25(3):669-82, vi. PubMed ID: 17659184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The structure of amyloid filaments in Alzheimer's disease and the unconventional virus infections of the nervous system.
    Masters CL; Beyreuther K
    Psychol Med; 1986 Nov; 16(4):735-7. PubMed ID: 3547446
    [No Abstract]   [Full Text] [Related]  

  • 27. RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.
    Hadar A; Milanesi E; Squassina A; Niola P; Chillotti C; Pasmanik-Chor M; Yaron O; Martásek P; Rehavi M; Weissglas-Volkov D; Shomron N; Gozes I; Gurwitz D
    Transl Psychiatry; 2016 Oct; 6(10):e909. PubMed ID: 27701409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [beta-Amyloid, cholinergic neurons and Alzheimer's disease].
    Kasparová J; Dolezal V
    Cesk Fysiol; 2002 May; 51(2):82-94. PubMed ID: 12053492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.
    Mattson MP; Rydel RE; Lieberburg I; Smith-Swintosky VL
    Ann N Y Acad Sci; 1993 May; 679():1-21. PubMed ID: 8512177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cellular lesions in Alzheimer's disease: structural and molecular analysis].
    Brion JP
    Bull Mem Acad R Med Belg; 1992; 147(11-12):481-9; discussion 490-1. PubMed ID: 1341572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer's disease.
    Hardy JA; Davies DC
    Br J Hosp Med; 1988 May; 39(5):372-3, 376-7. PubMed ID: 3289659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Closing in on the amyloid cascade: recent insights into the cell biology of Alzheimer's disease.
    Huse JT; Doms RW
    Mol Neurobiol; 2000; 22(1-3):81-98. PubMed ID: 11414282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid forming proteases: therapeutic targets for Alzheimer's disease.
    Schimmöller F; Higaki JN; Cordell B
    Curr Pharm Des; 2002; 8(28):2521-31. PubMed ID: 12369937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular properties underlying regional vulnerability to Alzheimer's disease pathology.
    Grothe MJ; Sepulcre J; Gonzalez-Escamilla G; Jelistratova I; Schöll M; Hansson O; Teipel SJ;
    Brain; 2018 Sep; 141(9):2755-2771. PubMed ID: 30016411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twenty Years of Presenilins--Important Proteins in Health and Disease.
    Walter J
    Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S41-8. PubMed ID: 26605647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular aspects of neurodegeneration in Alzheimer's disease.
    Russo C; Venezia V; Salis S; Dolcini V; Schettini G
    Funct Neurol; 2002; 17(2):65-70. PubMed ID: 12224792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of beta-amyloid in Alzheimer's disease.
    Sinha S
    Med Clin North Am; 2002 May; 86(3):629-39. PubMed ID: 12168562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's Disease-Current Status and Future Directions.
    Bhardwaj D; Mitra C; Narasimhulu CA; Riad A; Doomra M; Parthasarathy S
    J Med Food; 2017 Dec; 20(12):1141-1151. PubMed ID: 29131706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.